AKT1 and prostate cancer: For example, T0901317, a liver X receptor agonist, suppressed lipid raft-mediated Akt signalling affecting the localization and expression of flotillin-2 in a prostate cancer cell line, LNCaP, and a breast cancer cell line, MCF-7 [105,106].